Medicine
Pathophysiology and Management of Hepatic Encephalopathy
Quick fact
Hepatic encephalopathy is reversed by interventions that reduce gut-derived ammonia, such as the laxative lactulose, which traps ammonia in the colon.
Why this is interesting
Imagine a failing liver making the brain confused and drowsy. How does an organ in the belly alter our mind?
Read the full explanation
Understanding Pathophysiology and Management of Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a reversible brain dysfunction that occurs when the liver is too damaged to remove toxins from the blood. Normally, the liver converts ammonia (a byproduct of protein digestion and gut bacteria) into urea, which is excreted in urine. When the liver fails, or when blood bypasses the liver via portal-systemic shunts, ammonia enters the systemic circulation and reaches the brain. There, it disrupts the function of astrocytes, the support cells of the brain, leading to swelling and changes in neurotransmitter levels. The result is a spectrum of symptoms ranging from mild confusion and sleepiness to coma. Other toxins, like mercaptans and short-chain fatty acids, also contribute but ammonia is the primary culprit. Management focuses on lowering ammonia production and absorption: lactulose, a non-absorbable sugar, acidifies the colon and traps ammonia as ammonium; antibiotics like rifaximin reduce the ammonia-producing bacteria.
A deeper explanation
The underlying mechanism of hepatic encephalopathy involves a cascade beginning with impaired hepatic detoxification. In cirrhosis, hepatocytes lose their capacity to convert ammonia to urea, and portosystemic shunts deliver blood rich in ammonia directly to the systemic circulation. In the brain, ammonia crosses the blood-brain barrier and is taken up by astrocytes, which are the main site of ammonia detoxification in the CNS. Astrocytes incorporate ammonia into glutamine via glutamine synthetase, using glutamate as a substrate. This reaction consumes large amounts of glutamate, a major excitatory neurotransmitter, and produces glutamine, which is an osmotically active molecule. The accumulation of glutamine draws water into the astrocytes, causing them to swell. Astrocyte swelling impairs cellular function, including neurotransmitter uptake and ion homeostasis, leading to altered neuronal signaling. Moreover, ammonia indirectly enhances the inhibitory GABAergic tone by increasing the sensitivity of GABA-A receptors, possibly through interaction with benzodiazepine-like compounds that accumulate in liver failure. This results in a net decrease in excitatory neurotransmission, manifesting as the neuropsychiatric symptoms of HE. Management aims to reduce ammonia levels: lactulose is not absorbed and is metabolized by colonic bacteria to acids, thus acidifying the bowel lumen and converting NH3 to NH4+, which is non-absorbable; it also promotes osmotic diarrhea, expelling the toxin. Rifaximin, a poorly absorbed antibiotic, reduces the numbers of urease-producing gut bacteria, decreasing ammonia generation. In severe cases, protein restriction is sometimes used, though current guidelines recommend avoiding prolonged restriction. Identifying and treating precipitating factors, such as gastrointestinal bleeding, infections, electrolyte imbalance, and constipation, is crucial.